Affymetrix Sued over Pending eBioscience Deal; Firm Pushes Back Acquisition Date | GenomeWeb

Affymetrix is facing a lawsuit related to its imminent purchase of eBioscience. The firm has also pushed back the anticipated completion period for the deal, but said that the delay is not related to the new suit.

Tang Capital Partners, a San Diego-based investment fund, on Dec. 29, 2011, filed class action litigation in the Superior Court of California in the County of Santa Clara, Affy said last week in a filing with the US Securities and Exchange Commission.

The court does not make civil case documents available online.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.